Intrinsic Value of S&P & Nasdaq Contact Us

Nyxoah S.A. NYXH NASDAQ

NASDAQ Global Market • Healthcare • Medical - Instruments & Supplies • BE • USD

SharesGrow Score
50/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+196.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Nyxoah S.A. (NYXH) has a negative trailing P/E of -1.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 16.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -90.46%, forward earnings yield 6.26%. PEG 0.07 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.07); analyst target implies upside (+196.3%).
  • Forward P/E 16.0 — analysts expect a return to profitability with estimated EPS of $0.21 for FY2029.
  • PEG Ratio 0.07 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -90.46% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 6.26% as earnings recover.
  • Analyst consensus target $10.00 (+196.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 50/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
46/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NYXH

Valuation Multiples
P/E (TTM)-1.1
Forward P/E16.0
PEG Ratio0.07
Forward PEG0.07
P/B Ratio2.03
P/S Ratio9.25
EV/EBITDA-1.3
Per Share Data
EPS (TTM)$-2.24
Forward EPS (Est.)$0.21
Book Value / Share$1.22
Revenue / Share$0.25
FCF / Share$-1.74
Yields & Fair Value
Earnings Yield-90.46%
Forward Earnings Yield6.26%
Dividend Yield0.00%
Analyst Target$10.00 (+196.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2017 -40.3 0.00 92.27 0.00 -
2018 -48.2 3.44 41.83 0.00 -
2019 -48.3 2.31 173.00 0.00 -
2020 -29.0 -0.29 2.99 5,150.53 -
2021 -17.4 -0.25 3.24 564.83 -
2022 -3.9 -0.89 1.00 39.01 -
2023 -2.7 -0.10 1.20 27.00 -
2024 -4.3 -0.25 2.23 55.95 -
2025 -1.7 -0.05 3.04 14.89 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2017 $-0.50 $0.00 $-10.37M -
2018 $-0.43 $0.00 $-9.08M -
2019 $-0.34 $0.00 $-7.26M -
2020 $-0.68 $69K $-12.25M -17746.4%
2021 $-1.16 $852K $-27.62M -3241.7%
2022 $-1.21 $3.08M $-31.23M -1012.5%
2023 $-1.55 $4.35M $-43.21M -993.8%
2024 $-1.81 $4.52M $-59.24M -1310.2%
2025 $-2.37 $10.02M $-90.05M -899.1%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-1.82 $-1.99 – $-1.55 $31.79M $30.1M – $33.61M 3
2027 $-1.38 $-2.05 – $-0.93 $70.68M $64.65M – $73.75M 3
2028 $-0.86 $-0.94 – $-0.75 $120.26M $108.69M – $128.81M 1
2029 $0.21 $0.18 – $0.23 $251.36M $227.17M – $269.23M 1
2030 $0.70 $0.61 – $0.76 $361.51M $326.72M – $387.21M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message